INS and Insulin resistance: An animal study on pregnant mice found that TCS-treated mice had increased fasting blood glucose (FBG), insulin (INS), and homeostasis model assessment 2 of insulin resistance (HOMA2-IR) levels, and decreased homeostasis model assessment 2 of β cell function (HOMA2-β) [25].